- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
The global Parkinson’s Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parkinson’s Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Parkinson’s Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parkinson’s Disease Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
UCB
AbbVie
Acorda Therapeutics
Roche
Teva
Prothena
Orion Pharmaceuticals
Impax Pharmaceuticals
Voyager Therapeutics
MSD
Sunovion
Intec Pharma
GSK
Acadia
NeuroDerm
Adamas Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Parkinson’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Parkinson’s Disease Treatment
1.2 Classification of Parkinson’s Disease Treatment by Types
1.2.1 Global Parkinson’s Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Transdermal
1.2.5 Subcutaneous
1.2.6 Intestinal Infusion
1.3 Global Parkinson’s Disease Treatment Market by Application
1.3.1 Global Parkinson’s Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Parkinson’s Disease Treatment Market by Regions
1.4.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Parkinson’s Disease Treatment (2014-2024)
2 Company Profiles
2.1 UCB
2.1.1 Business Overview
2.1.2 Parkinson’s Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Parkinson’s Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Acorda Therapeutics
2.3.1 Business Overview
2.3.2 Parkinson’s Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Parkinson’s Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva
2.5.1 Business Overview
2.5.2 Parkinson’s Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Prothena
2.6.1 Business Overview
2.6.2 Parkinson’s Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Orion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Parkinson’s Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Impax Pharmaceuticals
2.8.1 Business Overview
2.8.2 Parkinson’s Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Voyager Therapeutics
2.9.1 Business Overview
2.9.2 Parkinson’s Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 MSD
2.10.1 Business Overview
2.10.2 Parkinson’s Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sunovion
2.11.1 Business Overview
2.11.2 Parkinson’s Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Intec Pharma
2.12.1 Business Overview
2.12.2 Parkinson’s Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 GSK
2.13.1 Business Overview
2.13.2 Parkinson’s Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 Acadia
2.14.1 Business Overview
2.14.2 Parkinson’s Disease Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 NeuroDerm
2.15.1 Business Overview
2.15.2 Parkinson’s Disease Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.16 Adamas Therapeutics
2.16.1 Business Overview
2.16.2 Parkinson’s Disease Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Parkinson’s Disease Treatment Market Competition, by Players
3.1 Global Parkinson’s Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson’s Disease Treatment Players Market Share
3.2.2 Top 10 Parkinson’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Parkinson’s Disease Treatment Market Size by Regions
4.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Parkinson’s Disease Treatment Revenue by Countries
5.1 North America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Parkinson’s Disease Treatment Revenue by Countries
6.1 Europe Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
7.2 China Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Parkinson’s Disease Treatment Revenue by Countries
8.1 South America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Parkinson’s Disease Treatment by Countries
9.1 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Parkinson’s Disease Treatment Market Segment by Type
10.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Parkinson’s Disease Treatment Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Transdermal Revenue Growth Rate (2014-2024)
10.5 Subcutaneous Revenue Growth Rate (2014-2024)
10.6 Intestinal Infusion Revenue Growth Rate (2014-2024)
11 Global Parkinson’s Disease Treatment Market Segment by Application
11.1 Global Parkinson’s Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Parkinson’s Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2014-2019)
11.4 Retail Pharmacy Revenue Growth (2014-2019)
11.5 Online Pharmacy Revenue Growth (2014-2019)
12 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Parkinson’s Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Parkinson’s Disease Treatment Picture
Table Product Specifications of Parkinson’s Disease Treatment
Table Global Parkinson’s Disease Treatment and Revenue (Mil
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
